Treatment with Optimal Dose Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Has a Positive Effect on Long-Term Survival in Older Individuals (Aged > 70 Years) and Octogenarians with Systolic Heart Failure
AuthID
P-00K-T5G
P-00K-T5G